Your email has been successfully added to our mailing list.

×
0.00288184438040346 0.00288184438040346 0.00288184438040346 0.00288184438040346 0.00288184438040346 -0.063400576368876 -0.063400576368876 -0.063400576368876
Stock impact report

Immune Pharmaceuticals Announces 2017 Financial Results

IMMUNE PHARMACEUTICALS INC NE (IMNP) 
US:NASDAQ Investor Relations: immunepharma.com/investor-relations
Company Research Source: Marketwire
ENGLEWOOD CLIFFS, NJ -- (Marketwired) -- 04/02/18 -- Immune Pharmaceuticals, Inc. (NASDAQ: IMNP) ("Immune" or the "Company"), a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases, today announced financial results for the year and quarter ended December 31, 2017. Elliot Maza, President and CEO of Immune, commented, "We made notable progress over the course of 2017. We worked diligently to focus our efforts and establish a clear path forward for bertilimumab and NanoCyclo by implementing our strategic corporate restructuring, prioritizing and segregating our research and development efforts, and strengthening our financial position. We have an excellent team in place to support our two exciting programs and advance the Company, and we are well positioned to have a breakthrough year in 2018. We are grateful to our shareholders for their support and look forward to achieving the milestones a Show less Read more
Impact Snapshot
Event Time:
IMNP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
Last price at news event
Since Event
Multi-day stock performance from the time of the news release
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
LAST
PRICE AT
NEWS EVENT
SINCE EVENT
Multi-day stock performance from the time of the news release
Last Price
VWAP
High:
Max Up
High:
Low:
Max Down
Low:
%
Post news range
%
Price change

Price Change Percentage


S&P 500
(SPX)

%

Volume ratio
%

Volume
Ticks

Avg transaction size

Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Opt-in for IMNP alerts
Opt-in for
IMNP alerts

from News Quantified
Opt-in for
IMNP alerts

from News Quantified